Calcium Channel Blocker Lacidipine Promotes Antitumor Immunity by Reprogramming Tryptophan Metabolism
Advanced Science · 2025
DOI: 10.1002/advs.202409310 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Yuwen Sheng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Natural Products Research, Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu, 610041, China. Hauptthemen laut MEDLINE: Tryptophan, Calcium Channel Blockers, Dihydropyridines, Breast Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Biological Resources Program, Chinese Academy of Sciences, Sichuan Science and Technology Program.
Abstract (Originalsprache)
Dysfunction of calcium channels is involved in the development and progression of some cancers. However, it remains unclear the role of calcium channel inhibitors in tumor immunomodulation. Here, calcium channel blocker lacidipine is identified to potently inhibit the enzymatic activity and expression of indoleamine 2,3‐dioxygenase 1 (IDO1), a rate‐limiting enzyme in tryptophan metabolism. Lacidipine activates effector T cells and incapacitates regulatory T cells (Tregs) to augment the anti‐tumor effect of chemotherapeutic agents in breast cancer by converting immunologically “cold” into “hot” tumors. Mechanistically, lacidipine targets calcium channels (Ca V 1.2/1.3) to inhibit Pyk2‐JAK1‐calmodulin complex‐mediated IDO1 transcription suppression, which suppresses the kynurenine pathway and maintains the total nicotinamide adenine dinucleotide (NAD) pool by regulating NAD biosynthesis. These results reveal a new function of calcium channels in IDO1‐mediated tryptophan metabolism in tumor immunity and warrant further development of lacidipine for the metabolic immunotherapy in breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Natural Products Research, Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu, 610041, China.
- School Of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, 511400, China.
- University of Chinese Academy of Sciences, Beijing, 100049, China.
- State Key Laboratory of Membrane Biology, School of Life Sciences, Institute for Immunology, Beijing Advanced Innovation Center for Structural Biology, Beijing Key Lab for Immunological Research on Chronic Diseases, Bei…
ORCID-Profile: Fei Wang
Förderung
- National Natural Science Foundation of China
- Biological Resources Program, Chinese Academy of Sciences
- Sichuan Science and Technology Program
- Key Projects of Chengdu Institute of Biology, Chinese Academy of Sciences
Zitieren
APA
Sheng, Y., Qiao, C., Zhang, Z., Shi, X., Yang, L., Xi, R., Yu, J., Liu, W., Zhang, G., & Wang, F. (2025). Calcium Channel Blocker Lacidipine Promotes Antitumor Immunity by Reprogramming Tryptophan Metabolism. Advanced Science. https://doi.org/10.1002/advs.202409310
Vancouver
Sheng Y, Qiao C, Zhang Z, Shi X, Yang L, Xi R, et al. Calcium Channel Blocker Lacidipine Promotes Antitumor Immunity by Reprogramming Tryptophan Metabolism. Advanced Science. 2025. doi:10.1002/advs.202409310
BibTeX
@article{Sheng2025,
author = {Sheng, Yuwen and Qiao, Chong and Zhang, Zhonghui and Shi, Xiaoke and Yang, Linhan and Xi, Ruiying and Yu, Jialing and Liu, Wanli and Zhang, Guolin and Wang, Fei},
title = {Calcium Channel Blocker Lacidipine Promotes Antitumor Immunity by Reprogramming Tryptophan Metabolism},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202409310}
}
EUVIMED